Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206.
Harriet M. Kluger
No relevant relationships to disclose
Susan Halabi
No relevant relationships to disclose
Nicole C Solomon
No relevant relationships to disclose
Lucia Jilaveanu
No relevant relationships to disclose
Christopher Zito
No relevant relationships to disclose
Joshua Sznol
No relevant relationships to disclose
Andrew B. Nixon
No relevant relationships to disclose
Brian I. Rini
Research Funding - Roche/Genentech
Eric Jay Small
No relevant relationships to disclose
Daniel J. George
Research Funding - Genentech